Access to COVID-19 Tools (ACT) Accelerator: "fair-share” contributions are beneficial to all.
Access to COVID-19 Tools (ACT) Accelerator: "fair-share” contributions are beneficial to all.
Funding the ACT Accelerator fairly is not an active charity; it's a global insurance policy to protect us all. Unprecedented international support drove USD 14.6 Bn in funding to the ACT Accelerator over 2020-21, but a USD 18.5 Bn gap remains for 2021.The “fair-share” contributions initiative will ensure equitable investment alongside equitable distribution of effective and safe vaccines, tests and treatments.
ACT Together. ACT now to end the COVID-19 pandemic.
More information: https://www.who.int/publications/m/item/how-to-fairly-share-the-financing-of-the-act-a---framework
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.